BMJ  2003;327:749 (27 September), doi:10.1136/bmj.327.7417.749

Letter

Communicating risks through analogies

The first 150 words of the full text of this article appear below.

EDITOR—Articles in this theme issue have described approaches that try to enhance the communication of risk by developing communication skills, using decision aids, and simplifying the representation of information. But when clinicians talk about actual risks with individual patients they often use analogies. We asked visitors to bmj.com to tell us some of their analogies.1 Many of their responses addressed screening and chronic disease—perhaps because they are both particularly fraught with difficulty.

The value of illustrations was reinforced by Barth, a surgeon: he described how he gives patients a digital picture of their scan that includes a risk calculation. This, of course, also indicates the extent of disease.

Many of the examples from readers try to convey the size of a risk. People know, for example, that smoking is a risk but find it difficult to comprehend its magnitude. Mackay relates how Richard Peto (responsible for many of . . . [Full text of this article]

Adrian Edwards, reader

Primary Care Group Swansea Clinical School, University of Wales, Swansea SA2 8PP a.g.k.edwards@swan.ac.uk


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Article

Communication and miscommunication of risk: understanding UK parents' attitudes to combined MMR vaccination
Paul Bellaby
BMJ 2003 327: 725-728. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

  • Visvanathan, K., Chlebowski, R. T., Hurley, P., Col, N. F., Ropka, M., Collyar, D., Morrow, M., Runowicz, C., Pritchard, K. I., Hagerty, K., Arun, B., Garber, J., Vogel, V. G., Wade, J. L., Brown, P., Cuzick, J., Kramer, B. S., Lippman, S. M. (2009). American Society of Clinical Oncology Clinical Practice Guideline Update on the Use of Pharmacologic Interventions Including Tamoxifen, Raloxifene, and Aromatase Inhibition for Breast Cancer Risk Reduction. JCO 27: 3235-3258 [Abstract] [Full text]  
  • Goldman, R. E., Parker, D. R., Eaton, C. B., Borkan, J. M., Gramling, R., Cover, R. T., Ahern, D. K. (2006). Patients' Perceptions of Cholesterol, Cardiovascular Disease Risk, and Risk Communication Strategies. Ann Fam Med 4: 205-212 [Abstract] [Full text]  

Rapid Responses:

Read all Rapid Responses

Analogy in medicine: Is it evidence based?
Amit Ghosh
bmj.com, 30 Sep 2003 [Full text]



Access jobs at BMJ Careers
Whats new online at Student 

BMJ